超肽生物科技股份有限公司 is engaged in the production and sale of precisely sequenced peptide raw materials and products, including health supplements, skincare products, and functional products upgraded by adding these ingredients to existing products. It has demonstrated significant performance in degenerative, metabolic, inflammatory, and athletic areas. Spanning a total of 15 years from research and development to sequencing production and validation, it has presented a total of 80 groups of sequenced peptides ranging from pentapeptides (5-peptides) to 49-peptides, all sourced from edible large fish and algae in the ocean. During this period, the company discussed the application technologies of protein cleavage with many well-known professors and industry experts, and further collaborated with the Development Center for Biotechnology (DCB) to design animal or cell experimental models based on the characteristics of each individual sequenced peptide or combined peptide, making the validation more precisely focused.

Currently, the types of sequenced peptides include mitochondrial type, molecular chaperone type, type I collagen type, interferon type, TGFβ2R type, Nakp ion type, T-cell CD4 type, TRAF3 type, STRF type, ACSL type involved in fatty acid decomposition, the newly named epidermal cell repair peptide JKS17, and even the modified peptide ACSL-2 to enhance and extend functionality.

Currently, various health supplements and skincare products have been developed.